AMENDMENT NO. 1 TO CONSULTING AGREEMENTConsulting Agreement • March 23rd, 2022 • Context Therapeutics Inc. • Pharmaceutical preparations
This AMENDMENT NO. 1 TO CONSULTING AGREEMENT (this “Amendment”) is entered into as of the 21st day of March 2022, but effective as of the 1st day of February, 2022 (the “Amendment Effective Date”), and is entered into by and between OncoStrategy LLC, (“Provider”) and Context Therapeutics Inc., a Delaware corporation, having its principal place of business at 2001 Market Street, Suite 3915, Unit#15, Philadelphia, PA 19103 (“Company”). Provider and Company are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
EMPLOYMENT AGREEMENTEmployment Agreement • March 23rd, 2022 • Context Therapeutics Inc. • Pharmaceutical preparations • Delaware
This EMPLOYMENT AGREEMENT (“Agreement”) is made and entered into effective as of this 22nd day of October, 2021 (“Effective Date”) by and between Context Therapeutics Inc. (the “Company”) and Alex Levit (“Executive”). The Company and Executive are each referred to herein as a “Party” or together as the “Parties.” Capitalized words not immediately defined shall have the meaning in the “Definitions” Section below.
